Shanti Mehta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shanti Mehta has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Dea Metko
Division of Dermatology, Department of Medicine, University of Toronto, ON, Canada
22 shared publications - Eric McMullen
Division of Dermatology, Department of Medicine University of Toronto Toronto Ontario Canada
14 shared publications Dea Metko
Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
6 shared publications- Mahan Maazi
Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
6 shared publications Cathryn Sibbald
4 shared publicationsDavid Croitoru
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada
4 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by Elsevier in Journal of the American Academy of Dermatology
Predictors of systemic treatment response in pediatric alopecia areata: A retrospective cohort study
- 8 August 2026
- Published by Elsevier in Journal of the American Academy of Dermatology
Open AccessPredictors of systemic treatment response in pediatric alopecia areata: A retrospective cohort study
- 27 May 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 30 (5)
Characterizing the Burden of Hand Dermatitis in Canada: A Cross-Sectional Survey of Disease Impact
- 27 May 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 30 (5)
Characterizing the Burden of Hand Dermatitis in Canada: A Cross-Sectional Survey of Disease Impact
- 5 May 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 30 (5)
Glucose Intolerance and Disease Activity in Hidradenitis Suppurativa: A Retrospective Cohort Study
- 5 May 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 30 (5)
Glucose Intolerance and Disease Activity in Hidradenitis Suppurativa: A Retrospective Cohort Study
- 16 July 2025
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 161 (9) , 966-969
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement
Importance: Psoriasis affects up to 3% of the population, with 30% of patients with psoriasis developing psoriatic arthritis (PsA), yet the transition between psoriasis and PsA has yet to be fully understood. Subclinical synovitis is a hallmark of PsA and is thought to precede psoriatic arthritis; its detection among patients with psoriasis without musculoskeletal (MSK) involvement through medical imaging modalities could offer valuable insights into the transition from psoriasis to PsA.Objective: To evaluate the prevalence of synovitis on ultrasonograms and magnetic resonance imaging (MRI) among patients with psoriasis without MSK involvement compared with healthy controls and patients with PsA.Data Sources: A comprehensive literature search was conducted in MEDLINE, Embase, Scopus, and Web of Science from inception to October 2024 using keywords related to psoriasis, synovitis, and medical imaging. A PROSPERO protocol was registered (CRD42024571308).Study Selection: Studies were eligible if they included patients with psoriasis without MSK involvement and assessed synovitis using imaging. Two reviewers independently screened studies and extracted data. Discrepancies were resolved by consensus. Twelve of 5132 initially identified studies met inclusion criteria.Data Extraction and Synthesis: Data were extracted per PRISMA guidelines. Risk of bias was assessed using the Newcastle-Ottawa Scale. A random-effects model was used to pool risk ratios (RRs) for synovitis prevalence across comparison groups. Heterogeneity was assessed using the I2 statistic.Main Outcomes and Measures: The primary outcome was the presence of imaging-detected synovitis among patients with psoriasis without MSK involvement compared with healthy controls and patients with PsA.Results: Twelve studies (N = 2606 patients) were included comprising 1593 patients with psoriasis (mean [SD] age, 46.4 [7.5] years; 982 men [61.6%]), 327 patients with PsA (mean [SD] age, 50.2 [7.1] years; 210 men [64.2%]), and 686 healthy controls (mean [SD] age, 45.7 [6.9] years; 281 of 576 men [48.8%]). Synovitis was 2.5 times more likely among patients with psoriasis than controls (RR, 2.55; 95% CI, 1.18-5.52). Detection rates were higher with MRI (RR, 6.40; 95% CI, 1.87-21.95) than ultrasonography (RR, 2.50; 95% CI, 1.10-5.67). Synovitis was more frequent among patients with PsA than those with psoriasis, but the difference was not statistically significant (RR, 0.50; 95% CI, 0.13-1.87).Conclusions and Relevance: This systematic review and meta-analysis found that subclinical synovitis is significantly more prevalent among patients with psoriasis without MSK involvement compared with healthy controls. This finding suggests that imaging may aid in identifying individuals at risk for progression to psoriatic arthritis.
- 16 July 2025
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 161 (9) , 966-969
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement
Importance: Psoriasis affects up to 3% of the population, with 30% of patients with psoriasis developing psoriatic arthritis (PsA), yet the transition between psoriasis and PsA has yet to be fully understood. Subclinical synovitis is a hallmark of PsA and is thought to precede psoriatic arthritis; its detection among patients with psoriasis without musculoskeletal (MSK) involvement through medical imaging modalities could offer valuable insights into the transition from psoriasis to PsA.Objective: To evaluate the prevalence of synovitis on ultrasonograms and magnetic resonance imaging (MRI) among patients with psoriasis without MSK involvement compared with healthy controls and patients with PsA.Data Sources: A comprehensive literature search was conducted in MEDLINE, Embase, Scopus, and Web of Science from inception to October 2024 using keywords related to psoriasis, synovitis, and medical imaging. A PROSPERO protocol was registered (CRD42024571308).Study Selection: Studies were eligible if they included patients with psoriasis without MSK involvement and assessed synovitis using imaging. Two reviewers independently screened studies and extracted data. Discrepancies were resolved by consensus. Twelve of 5132 initially identified studies met inclusion criteria.Data Extraction and Synthesis: Data were extracted per PRISMA guidelines. Risk of bias was assessed using the Newcastle-Ottawa Scale. A random-effects model was used to pool risk ratios (RRs) for synovitis prevalence across comparison groups. Heterogeneity was assessed using the I2 statistic.Main Outcomes and Measures: The primary outcome was the presence of imaging-detected synovitis among patients with psoriasis without MSK involvement compared with healthy controls and patients with PsA.Results: Twelve studies (N = 2606 patients) were included comprising 1593 patients with psoriasis (mean [SD] age, 46.4 [7.5] years; 982 men [61.6%]), 327 patients with PsA (mean [SD] age, 50.2 [7.1] years; 210 men [64.2%]), and 686 healthy controls (mean [SD] age, 45.7 [6.9] years; 281 of 576 men [48.8%]). Synovitis was 2.5 times more likely among patients with psoriasis than controls (RR, 2.55; 95% CI, 1.18-5.52). Detection rates were higher with MRI (RR, 6.40; 95% CI, 1.87-21.95) than ultrasonography (RR, 2.50; 95% CI, 1.10-5.67). Synovitis was more frequent among patients with PsA than those with psoriasis, but the difference was not statistically significant (RR, 0.50; 95% CI, 0.13-1.87).Conclusions and Relevance: This systematic review and meta-analysis found that subclinical synovitis is significantly more prevalent among patients with psoriasis without MSK involvement compared with healthy controls. This finding suggests that imaging may aid in identifying individuals at risk for progression to psoriatic arthritis.
- 9 July 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (12)
Efficacy and safety of dual biologic therapy in inflammatory skin diseases: A systematic review
- 9 July 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (12)
Efficacy and safety of dual biologic therapy in inflammatory skin diseases: A systematic review
- Open Access
- 4 July 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (1) , 157-159
Misdiagnoses of Hair and Scalp Disorders in Adult Patients With Skin of Color
- 4 July 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (1) , 157-159
Open AccessMisdiagnoses of Hair and Scalp Disorders in Adult Patients With Skin of Color
- 2 July 2025
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 26 (5) , 799-801
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review
- 2 July 2025
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 26 (5) , 799-801
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review
- 3 May 2025
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 30 (1) , 86-87
Non-Tuberculous Mycobacteria Infections in Sjögren’s Syndrome: A Systematic Review
- 3 May 2025
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 30 (1) , 86-87
Non-Tuberculous Mycobacteria Infections in Sjögren’s Syndrome: A Systematic Review
- 9 April 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (9) , 1741-1743
Lichen Planopilaris and the Lichen Planopilaris Mimickers: A Systematic Review
- 9 April 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (9) , 1741-1743
Lichen Planopilaris and the Lichen Planopilaris Mimickers: A Systematic Review